Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Philipp KarnerAudio: American English

Putin's Secret Plan to Live Forever (And 4 More Longevity Stories This Week)

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original textText language: English

This week in longevity: the Wall Street Journal reported on a state-backed Russian program targeting lab-grown replacement organs by 2030 — bioprinting, organs grown in animal hosts, and anti-aging gene therapy — though Russian scientists say almost none of it has surfaced in peer-reviewed journals (it also resurfaced that earlier hot-mic moment of Putin and Xi discussing organ replacement and immortality). We also cover a major review on why aging medicine may need to work differently in men and women, Cyclarity's first-in-human safety data on a molecule designed to pull plaque-driving 7-ketocholesterol out of arteries, an AI retinal scan that links eye aging to bone density and fracture risk across 46,000 people, and a blood-based "metabolomic clock" from a 220,000-person UK Biobank analysis that may flag dementia risk years before symptoms. Five real stories, what the data actually shows, and where the hype outruns the evidence. Subscribe for a new longevity roundup every week, and drop your questions below — I read them all.

Philipp Karner · 3 min · Source published: 2026-05-31

Added to Harbor: 10/29/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…